Boston-based Mass General Cancer Center researchers found that statins may help prevent the development of two cancers that result from chronic inflammation.
The Latest
There has been an uptick in aggressive, late-stage and rare cancers since the pandemic, and some point to COVID-19 as a possible link to the increase, The Washington Post reported June 6.
Memorial Medical Center in Las Cruces, N.M. — a 200-bed facility operated by Lifepoint Health — has been accused of turning away cancer patients, or demanding upfront payments before providing care, according to a June 5 report from NBC News…
New York City-based Memorial Sloan Kettering Cancer Center and National Cancer Institute researchers created an artificial intelligence tool that uses routine clinical data to predict the best immunotherapy drug and how a patient's cancer will respond to it.
University of Virginia Cancer Center is launching a partnership with seven federally qualified health centers across Virginia to increase cancer screening rates.
More cancer centers are turning to telehealth to expand their reach, with promising results for patients.
Cancer experts are increasingly optimistic about the potential for antibody-drug conjugates to become a standard treatment approach. The therapies involve attaching chemotherapy to an antibody to deliver targeted doses of chemo to cancer cells, with fewer side effects.
There's an aspect of patient life that many hospitals forget when creating a cancer treatment plan — fertility.
Little Rock-based The University of Arkansas for Medical Sciences created the Omar T. Atiq, MD, MACP, Distinguished Chair in Physician Leadership and appointed Dr. Atiq as the inaugural chair.
For the first time, a large study of young women had no new cases of cervical cancer after receiving the human papillomavirus vaccine.